drugset / Trial / NCT05940324
Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)
Phase 2
Recruiting
150 enrolled
Stanford University
National Institute of Mental Health (NIMH) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to understand how ketamine works in the brain to bring about a reduction in OCD symptoms.
Timeline
- Start
- 2024-02-24
- Primary completion
- 2028-11
- Completion
- 2028-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | 0.5 mg/kg | — |
| Subject | Naltrexone | Small molecule | 50 mg | Oral |